跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY - HSA Drug Approval Details
Approvals
/
HSA
/
APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY
Approved
THERAPEUTIC
APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY
APOTEX INC. (RICHMOND HILL) (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 22, 2017
Approval ID
f92d50bb7836d5c2
Company
APOTEX INC. (RICHMOND HILL) (CANADA)
Type
Therapeutic
Approval Details
Approval Id
f92d50bb7836d5c2
Drug Name
APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY
Product Name
APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY
Approval Number
SIN15323P
Approval Date
2017-08-22
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SPRAY, METERED
Route Of Administration
NASAL
Atc Code
R01AD09
Atc Item Name
mometasone
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Mometasone Furoate (Micronized)
50 mcg/metered spray
Mometasone Furoate (Micronized)
50 mcg/metered spray
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 22, 2017
Approval ID
f92d50bb7836d5c2
Type
Therapeutic
Back to HSA Approvals
